-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, UjX+SDOKZJHY4/CYeNI+/2CLjzKmJx2N1mZP2BZSRR3eSFU6vCe2reO2xwUpg8hJ Lt5VlMvdiY3DuBynzVEZPw== 0001140361-08-027007.txt : 20081203 0001140361-08-027007.hdr.sgml : 20081203 20081203164901 ACCESSION NUMBER: 0001140361-08-027007 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20081126 FILED AS OF DATE: 20081203 DATE AS OF CHANGE: 20081203 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SIGMA TAU FINANZIARIA SPA CENTRAL INDEX KEY: 0001092601 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-16929 FILM NUMBER: 081227909 MAIL ADDRESS: STREET 1: VIA SUDAFRICA 20 STREET 2: 00144 CITY: ROME ITALY FORMER NAME: FORMER CONFORMED NAME: SIGMA TAU FINANZIARIA DATE OF NAME CHANGE: 19990805 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SIGMA TAU INTERNATIONAL SA CENTRAL INDEX KEY: 0001170881 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-16929 FILM NUMBER: 081227908 BUSINESS ADDRESS: STREET 1: 18 AVENUE DE LA PORTE NEUVE CITY: LUXEMBOURG STATE: N4 ZIP: L-2227 MAIL ADDRESS: STREET 1: 18 AVENUE DE LA PORTE NEUVE CITY: LUXEMBOURG STATE: N4 ZIP: L-2227 FORMER NAME: FORMER CONFORMED NAME: SIGMA TAU FINANCE INTERNATIONAL SA DATE OF NAME CHANGE: 20020409 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DOR BIOPHARMA INC CENTRAL INDEX KEY: 0000812796 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 411505029 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 850 BEAR TAVERN ROAD STREET 2: SUITE 201 CITY: EWING STATE: NJ ZIP: 08628 BUSINESS PHONE: 609-538-8200 MAIL ADDRESS: STREET 1: 850 BEAR TAVERN ROAD STREET 2: SUITE 201 CITY: EWING STATE: NJ ZIP: 08628 FORMER COMPANY: FORMER CONFORMED NAME: ENDOREX CORP DATE OF NAME CHANGE: 19960916 FORMER COMPANY: FORMER CONFORMED NAME: IMMUNOTHERAPEUTICS INC DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sigma-Tau Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001385625 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-16929 FILM NUMBER: 081227906 BUSINESS ADDRESS: STREET 1: 800 SOUTH FREDERICK AVENUE STREET 2: SUITE 300 CITY: GAITHERSBURG STATE: MD ZIP: 20877 BUSINESS PHONE: 1-800-447-0169 MAIL ADDRESS: STREET 1: 800 SOUTH FREDERICK AVENUE STREET 2: SUITE 300 CITY: GAITHERSBURG STATE: MD ZIP: 20877 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sigma-Tau America S.A. CENTRAL INDEX KEY: 0001385930 STATE OF INCORPORATION: N4 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-16929 FILM NUMBER: 081227907 BUSINESS ADDRESS: STREET 1: 19-21, BOULEVARD DU PRINCE HENRI CITY: L-1724 LUXEMBOURG STATE: N4 ZIP: 00000 BUSINESS PHONE: 1-800-447-0169 MAIL ADDRESS: STREET 1: 19-21, BOULEVARD DU PRINCE HENRI CITY: L-1724 LUXEMBOURG STATE: N4 ZIP: 00000 3 1 doc1.xml FORM 3 X0203 3 2008-11-26 0 0000812796 DOR BIOPHARMA INC DORB 0001092601 SIGMA TAU FINANZIARIA SPA VIA SUDAFRICA, 20 ROME L6 00144 ITALY 0 0 1 0 0001170881 SIGMA TAU INTERNATIONAL SA 19-21 BLVD. DU PRINCE HENRI N4 L-1724 LUXEMBOURG 0 0 1 0 0001385930 Sigma-Tau America S.A. 19-21 BLVD. DU PRINCE HENRI N4 L-1724 LUXEMBOURG 0 0 1 0 0001385625 Sigma-Tau Pharmaceuticals, Inc. 800 S. FREDERICK AVE. SUITE 300 GAITHERSBURG MD 20877 0 0 1 0 Common Stock 16666667 I Indirect Shares directly owned by Sigma-Tau Pharmaceuticals, Inc. (?Pharmaceuticals?). Pharmaceuticals is a direct wholly-owned subsidiary of Sigma-Tau America S.A. (?America?). America is a direct wholly-owned subsidiary of Sigma-Tau International S.A. (?International?). International is a direct wholly-owned subsidiary of Sigma-Tau Finanziaria S.p.A. Exhibit List Exhibit 99 - Joint Filer Information /s/ Maurizio Terenzi, Proxy-holder authorized 2008-12-03 EX-99.1 2 misc1.htm MISCELLANEOUS EXHIBITS Unassociated Document
 
Exhibit 99
 


 
Joint Filer Information
Name:
Sigma-Tau International S.A.
   
Address:
  
 
19-21 Boulevard du Prince Henri
 
L-1724 Luxembourg
   
Designated Filer:
Sigma-Tau Finanziaria S.p.A.
   
Issuer & Ticker Symbol:
DOR BioPharma, Inc. (DORB)
   
Date of Earliest
  
Transaction Required
  
to be Reported:
11/26/08
   
Signature:
  /s/  Gregg Lapointe                                      
 
Name:  Gregg Lapointe
 
Title:    Attorney-in-fact
 
SIGMA-TAU INTERNATIONAL S.A.



 
 
 



Name:
Sigma-Tau America S.A.
   
Address:
19-21 Boulevard du Prince Henri
 
L-1724 Luxembourg
   
Designated Filer:
Sigma-Tau Finanziaria S.p.A.
   
Issuer & Ticker Symbol:
DOR BioPharma, Inc. (DORB)
   
Date of Earliest
  
Transaction Required
  
to be Reported:
11/26/08
   
Signature:
  /s/  Gregg Lapointe                           
 
Name:  Gregg Lapointe
 
Title:    Attorney-in-fact
 
SIGMA-TAU AMERICA S.A.



 
 
 


Name:
Sigma-Tau Pharmaceuticals, Inc.
   
Address:
800 South Frederick Avenue, Suite 300
 
Gaithersburg, Maryland  20877
 
USA
   
Designated Filer:
Sigma-Tau Finanziaria S.p.A.
   
Issuer & Ticker Symbol:
DOR BioPharma, Inc. (DORB)
   
Date of Earliest
  
Transaction Required
  
to be Reported:
11/26/08
   
Signature:
  /s/  Gregg Lapointe                                                 
 
Name:  Gregg Lapointe
 
Title:    Chief Executive Officer
 
SIGMA-TAU PHARMACEUTICALS, INC.


 
 
 

 -----END PRIVACY-ENHANCED MESSAGE-----